Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients

NCT01117662 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped The planned recruitment number of 180 Patient could not been achieved.

Conditions

Acute Rejection

Interventions

DRUG: Rituximab
DRUG: Placebo

Sponsor

Hannover Medical School

Collaborators

[object Object]